Djordje Atanackovic Selected Research

Djordje Atanackovic Research Topics

Disease

51	Neoplasms (Cancer) 02/2022 - 09/2002
35	Multiple Myeloma 12/2021 - 06/2006
15	Testicular Neoplasms (Testicular Cancer) 12/2020 - 03/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019 - 03/2004
5	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2013 - 06/2006
4	Stomach Neoplasms (Stomach Cancer) 10/2015 - 11/2010
3	B-Cell Lymphoma (Lymphoma, B Cell) 02/2022 - 01/2017
3	COVID-19 01/2022 - 07/2021
3	Lung Neoplasms (Lung Cancer) 01/2016 - 03/2004
3	Disease Progression 12/2015 - 02/2009
3	Adenocarcinoma 10/2015 - 09/2010
3	Colorectal Neoplasms (Colorectal Cancer) 09/2015 - 07/2010
3	Ascites 12/2013 - 04/2004
3	Human Influenza (Influenza) 06/2013 - 07/2003
3	Hyperthermia 03/2006 - 12/2002
2	Lymphoma (Lymphomas) 01/2022 - 01/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 12/2021 - 12/2020
2	Melanoma (Melanoma, Malignant) 05/2019 - 09/2014
2	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 02/2014
2	Residual Neoplasm 10/2015 - 01/2015
2	Squamous Cell Carcinoma of Head and Neck 09/2014 - 09/2006
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 12/2010
2	Neoplasm Metastasis (Metastasis) 06/2013 - 12/2009
1	Cytopenia 11/2021
1	Supraventricular Tachycardia 01/2018
1	Diarrhea 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2016
1	Neutropenia 10/2015
1	Chills 10/2015

Drug/Important Bio-Agent (IBA)

24	AntigensIBA 01/2022 - 09/2002
12	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2002
7	AntibodiesIBA 12/2021 - 07/2003
7	Monoclonal AntibodiesIBA 12/2020 - 06/2003
6	Chimeric Antigen ReceptorsIBA 02/2022 - 03/2016
5	CytokinesIBA 02/2014 - 09/2005
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2014 - 07/2010
5	EpitopesIBA 06/2013 - 09/2002
4	Biomarkers (Surrogate Marker)IBA 10/2018 - 10/2010
4	AutoantibodiesIBA 11/2014 - 01/2010
4	Peptides (Polypeptides)IBA 07/2010 - 09/2002
3	Epithelial Cell Adhesion MoleculeIBA 01/2018 - 12/2013
3	Interleukin-16 (Interleukin 16)IBA 07/2017 - 10/2010
3	Proteasome InhibitorsIBA 01/2017 - 01/2011
3	Biological ProductsIBA 12/2015 - 05/2010
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 12/2012
3	Indicators and Reagents (Reagents)IBA 12/2012 - 04/2004
3	Bortezomib (Velcade)FDA Link 01/2011 - 06/2006
2	VaccinesIBA 01/2022 - 03/2004
2	Antiviral Agents (Antivirals)IBA 12/2021 - 07/2021
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2012
2	daratumumabIBA 12/2021 - 01/2016
2	isatuximabIBA 12/2021 - 01/2020
2	Cancer VaccinesIBA 12/2020 - 03/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2020 - 06/2013
2	Hormones (Hormone)IBA 01/2016 - 03/2006
2	catumaxomabIBA 10/2015 - 12/2013
2	Bevacizumab (Avastin)FDA Link 09/2015 - 12/2009
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2014 - 09/2002
2	ErbB Receptors (EGF Receptor)IBA 06/2013 - 09/2010
2	Lenalidomide (CC 5013)FDA Link 02/2013 - 05/2010
2	Pharmaceutical PreparationsIBA 11/2010 - 12/2009
2	ChemokinesIBA 10/2010 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009 - 01/2008
2	Chemokine ReceptorsIBA 09/2005 - 04/2004
1	mRNA VaccinesIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Surface Antigens (Surface Antigen)IBA 12/2020
1	ProteomeIBA 12/2020
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2020
1	B-Cell Maturation AntigenIBA 04/2020
1	SurvivinIBA 05/2019
1	Messenger RNA (mRNA)IBA 05/2019
1	Glycoproteins (Glycoprotein)IBA 05/2019
1	SolventsIBA 11/2018
1	Aromatic HydrocarbonsIBA 11/2018
1	IpilimumabIBA 10/2018
1	SolitomabIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	EnzymesIBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Phosphotransferases (Kinase)IBA 07/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Immunomodulating AgentsIBA 01/2017
1	elotuzumabIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2015

Therapy/Procedure

22	Therapeutics 02/2022 - 12/2009
21	Immunotherapy 12/2021 - 09/2006
14	Drug Therapy (Chemotherapy) 03/2016 - 12/2002
13	Stem Cell Transplantation 07/2021 - 06/2006
2	Transplantation 02/2014 - 03/2013
1	Kidney Transplantation 07/2021
1	Immunomodulation 01/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Hormonal Contraception 01/2016
1	Combined Modality Therapy 10/2015
1	Neoadjuvant Therapy 10/2015
1	Adjuvant Chemotherapy 10/2015